跳至主要内容
临床试验/NCT04240925
NCT04240925Unknown不适用

Tolerability, Safety and Efficacy of Sigh During Non-invasive Mechanical Ventilation in Patients With Motor Neuron Disease- A Pilot Study

Ospedale San Raffaele2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2018年5月25日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
44
试验地点
2
主要终点
Changes in nocturnal oxygen desaturation index (ODI) assessed by transcutaneous nocturnal oximetric registration

研究概览

简要总结

Non-invasive mechanical ventilation (NIMV) is the recommended standard of care as initial therapy for patients with motor neuron disease (MND) with deterioration of the respiratory function.

SIGH_01 study is aimed at investigating the tolerability, safety profile and efficacy of sigh breaths during non-invasive mechanical ventilation in patients with MND in comparison to the standard ventilation support protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Willing and able to give informed consent
  • MND diagnosis according to El-Escorial criteria
  • Non-invasive ventilation indications in accordance with the international guidelines

排除标准

  • Inability to adhere to study visit schedule or lack of reliable caretaker
  • Presence of dementia
  • History of arrhythmia, heart failure or pneumothorax

结局指标

主要结局

Changes in nocturnal oxygen desaturation index (ODI) assessed by transcutaneous nocturnal oximetric registration

时间窗: Evaluation will be performed before NIMV initiation and two months after

次要结局

  • Changes in the arterial blood Ph assessed by arterial blood gas test(Evaluation will be performed before NIMV initiation and two months after)
  • Changes in self-perceived quality of life(QoL) assessed by 5-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-5). Score between 0 and 100 pts (higher score denotes worse QoL)(Evaluation will be performed before NIMV initiation and two months after)
  • Changes in the arterial blood PO2 concentration assessed by arterial blood gas test(Evaluation will be performed before NIMV initiation and two months after)
  • Changes in nocturnal dyspnoea assessed by Numeric Rating Scale (NRS). Score between 0 to 10, where higher scores denote a worse nocturnal dyspnoea.(Evaluation will be performed before NIMV initiation and two months after)
  • Changes in the arterial blood PCo2 concentration assessed by arterial blood gas test(Evaluation will be performed before NIMV initiation and two months after)
  • Changes in the forced vital capacity (FVC) assessed by spirometry test(Evaluation will be performed before NIMV initiation and two months after)
  • Changes in sleep quality assessed by Pittsburg Sleep Quality Index (PSQI) questionnaire. Score between 0 to 21, where higher scores denote a worse sleep quality.(Evaluation will be performed before NIMV initiation and two months after)
  • Changes in sleep quality assessed by Numeric Rating Scale (NRS). Score between 0 to 10, where higher scores denote a worse sleep quality.(Evaluation will be performed before NIMV initiation and two months after)

研究者

发起方
Ospedale San Raffaele
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nilo Riva

Principal Investigator

Ospedale San Raffaele

研究点 (2)

Loading locations...

相似试验